Implantable Ventricular Assist Devices
For patients not eligible for heart transplantation, Yale-New Haven's Heart Failure and Transplantation program can offer medical cardiac support with a ventricular assist device (VAD). VADs are surgically implanted medical pumps that take over much of the work for the heart. VADs may be used as a "bridge" to heart transplant, or as a primary treatment for advanced heart failure patients not eligible for heart transplantation, called destination therapy. The Heart Failure and Transplantation program offers an array of FDA-approved devices including the Thoratec HeartMate II® and Thoratec HeartMate® XVE.
LVAD as a permanent solution
Yale-New Haven Hospital (YNHH) has received certification from the Joint Commission - the nation's predominant standards-setting and accrediting body in health care - to implant left ventricular assist devices (LVADs) into patients with end-stage heart failure as a permanent or destination therapy, not just as a temporary bridge to transplant..
Yale-New Haven Transplantation Center (YNHTC) provides expert, comprehensive and compassionate care for adult and pediatric patients throughout the world who are candidates for organ transplantation. YNHTC team members perform liver, kidney, pancreas and heart transplantation. It is the region's leader in the evaluation and treatment of advanced liver disease.
In addition, YNHTC provides vascular access for patients who require dialysis treatment. YNHTC offers innovative treatments and access to research trials for patients suffering from a wide range of conditions.